US equities
|
MU
$967.72
▲+4.19%
SPCX
$144.24
▼-2.92%
TSLA
$398.73
▼-2.14%
META
$614.60
▼-0.90%
SNDK
$1,359.00
▲+4.15%
NVDA
$218.26
▲+0.15%
SKHY
$160.01
▲+10.08%
GOOGL
$324.15
▲+1.12%
MU
$967.72
▲+4.19%
SPCX
$144.24
▼-2.92%
TSLA
$398.73
▼-2.14%
META
$614.60
▼-0.90%
SNDK
$1,359.00
▲+4.15%
NVDA
$218.26
▲+0.15%
SKHY
$160.01
▲+10.08%
GOOGL
$324.15
▲+1.12%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about J/R/ Rahn
Recent news which mentions J/R/ Rahn
From Pharma To Psychedelics, Robert Barrow, CEO Of MindMed: Meet Our Speakers
April 04, 2022
Tickers
MNMD
Tags
Psychedelics
MindMed
News
From
Benzinga
EXCLUSIVE: MindMed CEO Rob Barrow On Growth Aspirations, Development Pipeline
December 10, 2021
Tickers
MNMD
NDAQ
Tags
Benzinga
Robert Barrow
MNMD
From
Benzinga
EXCLUSIVE: Kevin O'Leary Unpacks Deal Flow, Investments, Perspectives On Disruptive Innovation
August 31, 2021
Tickers
IPOS
MNMD
Tags
Media
Cryptocurrency
$ETH
From
Benzinga